Two groups of novel hydroxypyridinone derivatives 6(a-e) and 12(a-c), were designed as potential tyrosinase inhibitors, and synthesized using kojic acid as a starting material. The tyrosinase inhibitory activity of these two groups was demonstrated to be potent, especially compounds 6e and 12a, whose IC 50 values for monophenolase activity were 1.95 µM and 2.79 µM, respectively. Both of these values are lower than that of kojic acid (IC 50 = 12.50 µM). Compounds 6e and 12a
Tyrosinase (EC 1.14.18.1), a multifunctional copper-containing enzyme from the oxidase superfamily, is widely distributed in mammals, plants, microorganisms, and insects. 1 The active site of tyrosinase is well conserved among the different species.
Six histidine residues, which are provided by a fourhelical bundle, coordinate the two copper ions, which serve as the major cofactors in the active site. 2, 3 Tyrosinase can catalyze the first and rate-limiting step of melanin formation, namely the hydroxylation of L-tyrosine to L-3- (3,4-dihydroxyphenyl) -alanine (L-DOPA) (monophenolase activity) and also the subsequent oxidation of DOPA to dopaquinone (diphenolase activity). 4 Dopaquinone is highly reactive and can polymerize spontaneously to form melanin in a series of reaction pathways. 5 Therefore, tyrosinase plays an important role in the pigmentation of skin, 6, 7 the browning of fruits and vegetables, 8, 9 wound healing, 10 and cuticle formation in insects. 11, 12 Tyrosinase is also involved in neuromelanin formation in the brain and neurodegeneration associated with Parkinson's disease. 13, 14 Thus, tyrosinase inhibitors have attracted increasing attention. In principle, tyrosinase inhibitors have potential applications in the agricultural, cosmetic and pharmaceutical industry.
Numerous effects have been made to develop potent and safe tyrosinase inhibitors from natural materials and synthetic methods. [15] [16] [17] [18] [19] However, only a few are sufficiently potent for practical use and comply with the general safety regulations.
Thus, there is a demand for novel tyrosinase inhibitors with superior activity together with reduced side effects. Kojic acid (1), a metabolic product of many species of Aspergillus and Penicillium moulds, has been used as an ingredient in cosmetics and as an anti-browning agent in foods that rapidly change colour by virtue of its appreciable anti-tyrosinase and antioxidant activities. [20] [21] [22] [23] Thus, modification of kojic acid provides a potential route for superior tyrosinase inhibitors. [24] [25] [26] [27] Kojic acid has been demonstrated to inhibit tyrosinase by chelating the copper ion normally present in the active site of tyrosinase. Using the principle of bioisosterism, we have changed the "O" at position-1 in pyranone ring to "NH", synthesizing a range of hydroxypyridinone-amino acid and hydroxypyridinone-dipeptide conjugates. Their tyrosinase inhibitory activity and mechanism of inhibition have been investigated.
Hydroxypyridinone-L-amino acid conjugates (6) were synthesized starting from kojic acid (1) (Scheme 1). Benzylation of 5-hydroxy group in kojic acid was achieved by the reaction of kojic acid and benzyl chloride under basic condition to provide 2 in good yield (80%). Condensation of 2 with ammonia generated 3 (74%), which was then subjected to hydrogenation to remove benzyl group, providing compound 4 (82%). Coupling of 4 with Cbz-L-amino acid (5) via ester bond was carried out in the presence of EDC and DMAP in DMF at room temperature, yielding product 6. The synthetic route of hydroxypyridinone-dipeptide conjugates (12) is presented in Scheme 2. Compound 3 was treated with thionyl chloride, followed by the reaction with aqueous ammonia, providing amino group-containing compound 7. N-benzyl oxygen carbonyl-L-phenylalanine (5a) reacted with methyl ester of L-amino acid (8) in the presence of HCTU, generating compounds 9, which were then hydrolyzed to produce compounds 10. The coupling of 10 with 7 was achieved in the presence of HCTU, yielding compounds 11, which were subjected to hydrogenation in the presence of Pd/C catalyst, providing hydroxypyridinone-dipeptide conjugates 12. 29 All the compounds have been fully characterized by 1 H NMR, 13 The inhibitory effects on mushroom tyrosinase increased with the increase of concentrations of hydroxypyridinone derivatives ( Figure 1 ). As shown in Figure 1A , the inhibitory activity of compounds 6 follows the order: 6e > 6a > 6d > 6c > 6b. The IC 50 values of compounds 6a-6e were calculated to be 11.76, 28.71, 15.62, 12.48 and 1.95 μM respectively. Among these five hydroxypyridinone-amino acid derivatives, compound 6e was found to exhibit the strongest inhibition against monophenolase activity of tyrosinase, being 6.4-fold more active than kojic acid (IC 50 = 12.50 μM).
Based on the data presented in Figure 1B that the inhibitory activity mainly depends on the complimentary fit between the compound and active site of enzyme, which is affected by the substituting group and position on the pyridinone ring. In our previous study, it was found that hydroxypyridinone derivatives with a substitute at position-2 in pyridine ring had hardly anti-tyrosinase activity, although they have superior copper-binding affinity and higher lipophilicity than kojic acid. The inhibitory mechanism of 6e and 12a on mushroom tyrosinase was investigated using L-DOPA as a substrate. For both compounds, investigation on the relationship between enzyme activity and its concentration in the presence of compound 6e and 12a indicated that the plots of the remaining enzyme activity versus the concentration of enzyme at different inhibitor concentrations gave a family of straight lines, which all passed through the origin (Figure 4 ). This result is similar to that reported by Chen et al. 32 Increase of inhibitor concentration resulted in descent of the slope of the line, indicating that the presence of inhibitor resulted in the inhibition of enzyme activity. 33 Thus, the inhibition of both compounds 6e and 12a on diphenolase activity of tyrosinase is reversible. In order to further investigate the inhibitory mechanism of hydroxypyridinone derivatives, copper reduction capacity 34 and copper chelating ability 35 of compound 6e were determined. The capacity of the reducing cupric ion to cuprous ion by 6e at different concentrations is shown in Figure 6A . As shown in Figure 6B , at low concentrations (<1mM), the copper chelating ability of compound 6e and kojic acid both increased with increasing concentration (P ability of 6e to that of kojic acid. Tyrosinase contains a coupled binuclear copper center in its active site. The two cupric ions, bound with three histidine residues, are directly involved in the different catalytic activities. When compound 6e enters the active site of the tyrosinase, it could outcompete with the histidine residues for the binding of cupric ion, thereby resulting in a loss of activity. The copper chelating activity of 6e was in accordance with its tyrosinase inhibitory activity (Figure 1) .
Therefore, copper chelation of 6e is one of the important mechanisms for the inhibition of tyrosinase.
In order to understand the interaction mode of inhibitor binding to tyrosinase, the molecular docking of compound 6e to Agaricus bisporus tyrosinase 38 In summary, a range of hydroxypyridinone derivatives were synthesized in the present study. Among them, 6e was found to exhibit the highest tyrosinase inhibitory activity. 6e exhibited reversible and mixed type inhibition on mushroom tyrosinase.
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Chelating copper at the active site of tyrosinase is an important mechanism for the inhibition of tyrosinase. Thus it could find application in medicine, cosmetic and agriculture areas. 
